Anke Görlitz

A randomized, double‐blind, phase 2 study of erythropoietin in optic neuritis

Kurt‐Wolfram Sühs, Katharina Hein, Muriel B. Sättler et al. · Annals of Neurology · 2012 · 152 citations

Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial

Justin Hasenkamp, Gerald Wulf, Peter Dreger et al. · The Lancet Oncology · 2014 · 108 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +10

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

Tim Friede, Reinhard Hilgers, Anke Görlitz et al. · ISRN Pediatrics · 2012 · 78 citations · Full text

Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study

Rolf Wachter, Rosine Lahno, Beatrice Haase et al. · PLoS ONE · 2012 · 66 citations · Full text

Rituximab for Graft-Versus-Host-Disease-Prophylaxis after Allogeneic Stem Cell Transplantation Given as Treatment of High Risk Relapse of Aggressive Lymphoma: Results of a Randomized Phase II Study.

Justin Hasenkamp, Anke Görlitz, Peter Dreger et al. · Blood · 2008 · 14 citations